Prevention of P2 Receptor-Dependent Thrombocyte Activation by Pore-Forming Bacterial Toxins Improves Outcome in a Murine Model of Urosepsis
Urosepsis is a potentially life-threatening, systemic reaction to uropathogenic bacteria entering the bloodstream of the host. One of the hallmarks of sepsis is early thrombocyte activation with a following fall in circulating thrombocytes as a result of intravascular aggregation and sequestering of...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-08-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/21/16/5652 |
id |
doaj-f3c1a68d977641f2a0843a86ea2e006e |
---|---|
record_format |
Article |
spelling |
doaj-f3c1a68d977641f2a0843a86ea2e006e2020-11-25T02:47:49ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672020-08-01215652565210.3390/ijms21165652Prevention of P2 Receptor-Dependent Thrombocyte Activation by Pore-Forming Bacterial Toxins Improves Outcome in a Murine Model of UrosepsisMette G. Christensen0Nanna Johnsen1Marianne Skals2Aimi D. M. Hamilton3Peter Rubak4Anne-Mette Hvas5Helle Praetorius6Department of Biomedicine, Aarhus University, 8000 Aarhus C, DenmarkDepartment of Biomedicine, Aarhus University, 8000 Aarhus C, DenmarkDepartment of Biomedicine, Aarhus University, 8000 Aarhus C, DenmarkDepartment of Biomedicine, Aarhus University, 8000 Aarhus C, DenmarkClinic for Diagnostics, Aalborg University Hospital, 9000 Aalborg, DenmarkDepartment of Clinical Biochemistry, Aarhus University Hospital, 8000 Aarhus C, DenmarkDepartment of Biomedicine, Aarhus University, 8000 Aarhus C, DenmarkUrosepsis is a potentially life-threatening, systemic reaction to uropathogenic bacteria entering the bloodstream of the host. One of the hallmarks of sepsis is early thrombocyte activation with a following fall in circulating thrombocytes as a result of intravascular aggregation and sequestering of thrombocytes in the major organs. Development of a thrombocytopenic state is associated with a poorer outcome of sepsis. Uropathogenic <i>Escherichia coli</i> frequently produce the pore-forming, virulence factor α-haemolysin (HlyA), of which the biological effects are mediated by ATP release and subsequent activation of P2 receptors. Thus, we speculated that inhibition of thrombocyte P2Y<sub>1</sub> and P2Y<sub>12</sub> receptors might ameliorate the septic response to HlyA-producing <i>E. coli</i>. The study combined in vitro measurements of toxin-induced thrombocyte activation assessed as increased membrane abundance of P-selectin, fibronectin and CD63 and data from in vivo murine model of sepsis-induced by HlyA-producing <i>E. coli</i> under infusion of P2Y<sub>1</sub> and P2Y<sub>12</sub> antagonists. Our data show that the P2Y<sub>1</sub> receptor antagonist almost abolishes thrombocyte activation by pore-forming bacterial toxins. Inhibition of P2Y<sub>1</sub>, by constant infusion of MRS2500, markedly increased the survival in mice with induced sepsis. Moreover, MRS2500 partially prevented the sepsis-induced depletion of circulating thrombocytes and dampened the sepsis-associated increase in proinflammatory cytokines. In contrast, P2Y<sub>12</sub> receptor inhibition had only a marginal effect in vivo and in vitro. Taken together, inhibition of the P2Y<sub>1</sub> receptor gives a subtle dampening of the thrombocyte activation and the cytokine response to bacteraemia, which may explain the improved survival observed by P2Y<sub>1</sub> receptor antagonists.https://www.mdpi.com/1422-0067/21/16/5652P2Y<sub>1</sub>P2Y<sub>12</sub>sepsis<i>Escherichia</i> <i>coli</i>HlyAthrombocytes |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Mette G. Christensen Nanna Johnsen Marianne Skals Aimi D. M. Hamilton Peter Rubak Anne-Mette Hvas Helle Praetorius |
spellingShingle |
Mette G. Christensen Nanna Johnsen Marianne Skals Aimi D. M. Hamilton Peter Rubak Anne-Mette Hvas Helle Praetorius Prevention of P2 Receptor-Dependent Thrombocyte Activation by Pore-Forming Bacterial Toxins Improves Outcome in a Murine Model of Urosepsis International Journal of Molecular Sciences P2Y<sub>1</sub> P2Y<sub>12</sub> sepsis <i>Escherichia</i> <i>coli</i> HlyA thrombocytes |
author_facet |
Mette G. Christensen Nanna Johnsen Marianne Skals Aimi D. M. Hamilton Peter Rubak Anne-Mette Hvas Helle Praetorius |
author_sort |
Mette G. Christensen |
title |
Prevention of P2 Receptor-Dependent Thrombocyte Activation by Pore-Forming Bacterial Toxins Improves Outcome in a Murine Model of Urosepsis |
title_short |
Prevention of P2 Receptor-Dependent Thrombocyte Activation by Pore-Forming Bacterial Toxins Improves Outcome in a Murine Model of Urosepsis |
title_full |
Prevention of P2 Receptor-Dependent Thrombocyte Activation by Pore-Forming Bacterial Toxins Improves Outcome in a Murine Model of Urosepsis |
title_fullStr |
Prevention of P2 Receptor-Dependent Thrombocyte Activation by Pore-Forming Bacterial Toxins Improves Outcome in a Murine Model of Urosepsis |
title_full_unstemmed |
Prevention of P2 Receptor-Dependent Thrombocyte Activation by Pore-Forming Bacterial Toxins Improves Outcome in a Murine Model of Urosepsis |
title_sort |
prevention of p2 receptor-dependent thrombocyte activation by pore-forming bacterial toxins improves outcome in a murine model of urosepsis |
publisher |
MDPI AG |
series |
International Journal of Molecular Sciences |
issn |
1661-6596 1422-0067 |
publishDate |
2020-08-01 |
description |
Urosepsis is a potentially life-threatening, systemic reaction to uropathogenic bacteria entering the bloodstream of the host. One of the hallmarks of sepsis is early thrombocyte activation with a following fall in circulating thrombocytes as a result of intravascular aggregation and sequestering of thrombocytes in the major organs. Development of a thrombocytopenic state is associated with a poorer outcome of sepsis. Uropathogenic <i>Escherichia coli</i> frequently produce the pore-forming, virulence factor α-haemolysin (HlyA), of which the biological effects are mediated by ATP release and subsequent activation of P2 receptors. Thus, we speculated that inhibition of thrombocyte P2Y<sub>1</sub> and P2Y<sub>12</sub> receptors might ameliorate the septic response to HlyA-producing <i>E. coli</i>. The study combined in vitro measurements of toxin-induced thrombocyte activation assessed as increased membrane abundance of P-selectin, fibronectin and CD63 and data from in vivo murine model of sepsis-induced by HlyA-producing <i>E. coli</i> under infusion of P2Y<sub>1</sub> and P2Y<sub>12</sub> antagonists. Our data show that the P2Y<sub>1</sub> receptor antagonist almost abolishes thrombocyte activation by pore-forming bacterial toxins. Inhibition of P2Y<sub>1</sub>, by constant infusion of MRS2500, markedly increased the survival in mice with induced sepsis. Moreover, MRS2500 partially prevented the sepsis-induced depletion of circulating thrombocytes and dampened the sepsis-associated increase in proinflammatory cytokines. In contrast, P2Y<sub>12</sub> receptor inhibition had only a marginal effect in vivo and in vitro. Taken together, inhibition of the P2Y<sub>1</sub> receptor gives a subtle dampening of the thrombocyte activation and the cytokine response to bacteraemia, which may explain the improved survival observed by P2Y<sub>1</sub> receptor antagonists. |
topic |
P2Y<sub>1</sub> P2Y<sub>12</sub> sepsis <i>Escherichia</i> <i>coli</i> HlyA thrombocytes |
url |
https://www.mdpi.com/1422-0067/21/16/5652 |
work_keys_str_mv |
AT mettegchristensen preventionofp2receptordependentthrombocyteactivationbyporeformingbacterialtoxinsimprovesoutcomeinamurinemodelofurosepsis AT nannajohnsen preventionofp2receptordependentthrombocyteactivationbyporeformingbacterialtoxinsimprovesoutcomeinamurinemodelofurosepsis AT marianneskals preventionofp2receptordependentthrombocyteactivationbyporeformingbacterialtoxinsimprovesoutcomeinamurinemodelofurosepsis AT aimidmhamilton preventionofp2receptordependentthrombocyteactivationbyporeformingbacterialtoxinsimprovesoutcomeinamurinemodelofurosepsis AT peterrubak preventionofp2receptordependentthrombocyteactivationbyporeformingbacterialtoxinsimprovesoutcomeinamurinemodelofurosepsis AT annemettehvas preventionofp2receptordependentthrombocyteactivationbyporeformingbacterialtoxinsimprovesoutcomeinamurinemodelofurosepsis AT hellepraetorius preventionofp2receptordependentthrombocyteactivationbyporeformingbacterialtoxinsimprovesoutcomeinamurinemodelofurosepsis |
_version_ |
1724751065393397760 |